China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Antiviral Treatment Strategies to Improve the Clinical Cure Rate and Reduce the Relapse Rate of Chronic Hepatitis B'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132929
Registration Time: 2026/09/20
Type: Interventional study
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344398
Published by HT Digital Content Services with permission from Health Daily Digest....